The 10 biggest device players in healthcare — Medtronic, Stryker & more

Written by Angie Stewart | May 16, 2019 | Print  | Email

Medtronic and Johnson & Johnson are two of the most powerful public companies in healthcare, according to Forbes.

Forbes determined the most powerful companies using a composite score of revenue, profit, assets and market value. Forbes analyzed companies' financial results for the 12 months ending on April 18, 2019.

Ten devicemakers that made the "2019 Forbes Global 2000" list:

Johnson & Johnson (No. 37)
Sales: $81.6 billion
Profits: $14.7 billion
Assets: $153 billion
Market value: $366.2 billion

Medtronic (No. 150)
Sales: $30.6 billion
Profits: $4.9 billion
Assets: $88.7 billion
Market value: $113 billion

Becton Dickinson (No. 355)
Sales: $17.1 billion
Profits: $1 billion
Assets: $52.9 billion
Market value: $61.3 billion

Stryker (No. 366)
Sales: $13.6 billion
Profits: $3.6 billion
Assets: $27.2 billion
Market value: $67.3 billion

Boston Scientific (No. 557)
Sales: $9.8 billion
Profits: $1.7 billion
Assets: $21 billion
Market value: $48.8 billion

Intuitive Surgical (No. 1,013)
Sales: $3.7 billion
Profits: $1.1 billion
Assets: $7.8 billion
Market value: $60.9 billion

Zimmer Biomet (No. 1,027)
Sales: $7.9 billion
Profits: -$379 million
Assets: $24.1 billion
Market value: $24.6 billion

Henry Schein (No. 1,248)
Sales: $13.2 billion
Profits: $536 million
Assets: $8.5 billion
Market value: $9.2 billion

DaVita (No. 1,313)
Sales: $11.4 billion
Profits: $159 million
Assets: $19.3 billion
Market value: $8.7 billion

Smith & Nephew (No. 1,377)
Sales: $4.9 billion
Profits: $666 million
Assets: $8.1 billion
Market value: $16.4 billion

More articles on devices:
Xtant Q1 revenue drops 6.7%, net loss hits $2.8M: 4 key notes
10 major Medtronic moves in 2019
Stryker's strategy for Mako, K2M, sports medicine going forward

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.